{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:09:28Z","timestamp":1784646568978,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100018552","name":"Taizhou Science and Technology Plan Project","doi-asserted-by":"crossref","award":["20ywb06"],"award-info":[{"award-number":["20ywb06"]}],"id":[{"id":"10.13039\/501100018552","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhejiang Provincial Basic and Public Welfare Research Program","award":["LGF20H090009"],"award-info":[{"award-number":["LGF20H090009"]}]},{"name":"Zhejiang Provincial Basic and Public Welfare Research Program","award":["LGD20H310002"],"award-info":[{"award-number":["LGD20H310002"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["81903584"],"award-info":[{"award-number":["81903584"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11064-025-04557-x","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T08:49:11Z","timestamp":1758185351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sinomenine Modifies Parkinson\u2019s Disease Through Nrf2 Activation"],"prefix":"10.1007","volume":"50","author":[{"given":"Lingling","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qirou","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengli","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"4557_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/s0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C (2024) The epidemiology of Parkinson\u2019s disease. Lancet 403:283\u2013292. https:\/\/doi.org\/10.1016\/s0140-6736(23)01419-8","journal-title":"Lancet"},{"key":"4557_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/14737175.2023.2177535","volume":"23","author":"A Lenka","year":"2023","unstructured":"Lenka A, Jankovic J (2023) How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson\u2019s disease? Expert Rev Neurother 23:107\u2013122. https:\/\/doi.org\/10.1080\/14737175.2023.2177535","journal-title":"Expert Rev Neurother"},{"key":"4557_CR3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41582-024-01034-x","volume":"20","author":"F Stocchi","year":"2024","unstructured":"Stocchi F, Bravi D, Emmi A, Antonini A (2024) Parkinson disease therapy: current strategies and future research priorities. Nat Rev Neurol 20:695\u2013707. https:\/\/doi.org\/10.1038\/s41582-024-01034-x","journal-title":"Nat Rev Neurol"},{"key":"4557_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/jnc.14898","volume":"152","author":"H Li","year":"2020","unstructured":"Li H, Yang P, Knight W, Guo Y, Perlmutter JS, Benzinger TLS, Morris JC, Xu J (2020) The interactions of dopamine and oxidative damage in the striatum of patients with neurodegenerative diseases. J Neurochem 152:235\u2013251. https:\/\/doi.org\/10.1111\/jnc.14898","journal-title":"J Neurochem"},{"key":"4557_CR5","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1007\/s11064-018-02711-2","volume":"44","author":"AP Gureev","year":"2019","unstructured":"Gureev AP, Popov VN (2019) Nrf2\/ARE pathway as a therapeutic target for the treatment of Parkinson diseases. Neurochem Res 44:2273\u20132279. https:\/\/doi.org\/10.1007\/s11064-018-02711-2","journal-title":"Neurochem Res"},{"key":"4557_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41582-019-0155-7","volume":"15","author":"A Elkouzi","year":"2019","unstructured":"Elkouzi A, Vedam-Mai V, Eisinger RS, Okun MS (2019) Emerging therapies in Parkinson disease - repurposed drugs and new approaches. Nat Rev Neurol 15:204\u2013223. https:\/\/doi.org\/10.1038\/s41582-019-0155-7","journal-title":"Nat Rev Neurol"},{"key":"4557_CR7","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s10571-017-0469-1","volume":"37","author":"H Fan","year":"2017","unstructured":"Fan H, Shu Q, Guan X, Zhao J, Yan J, Li X, Liu J, Jia Z, Shi J, Li J (2017) Sinomenine protects PC12 neuronal cells against H2O2-induced cytotoxicity and oxidative stress via a ROS-dependent up-regulation of endogenous antioxidant system. Cell Mol Neurobiol 37:1387\u20131398. https:\/\/doi.org\/10.1007\/s10571-017-0469-1","journal-title":"Cell Mol Neurobiol"},{"key":"4557_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.784154","volume":"15","author":"X Liu","year":"2021","unstructured":"Liu X, Wu G, Tang N, Li L, Liu C, Wang F, Ke S (2021) Glymphatic drainage blocking aggravates brain edema, neuroinflammation via modulating TNF-\u03b1, IL-10, and AQP4 after intracerebral hemorrhage in rats. Front Cell Neurosci 15:784154. https:\/\/doi.org\/10.3389\/fncel.2021.784154","journal-title":"Front Cell Neurosci"},{"key":"4557_CR9","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.3892\/mmr.2017.8277","volume":"17","author":"RJ Su","year":"2018","unstructured":"Su RJ, Zhen JL, Wang W, Zhang JL, Zheng Y, Wang XM (2018) Time-course behavioral features are correlated with Parkinson\u2019s disease\u2013associated pathology in a 6-hydroxydopamine hemiparkinsonian rat model. Mol Med Rep 17:3356\u20133363. https:\/\/doi.org\/10.3892\/mmr.2017.8277","journal-title":"Mol Med Rep"},{"key":"4557_CR10","doi-asserted-by":"publisher","DOI":"10.3791\/57648","author":"K Young","year":"2018","unstructured":"Young K, Morrison H (2018) Quantifying microglia morphology from photomicrographs of immunohistochemistry prepared tissue using Image. J Vis Exp. https:\/\/doi.org\/10.3791\/57648","journal-title":"J Vis Exp"},{"key":"4557_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.914518","volume":"13","author":"M Liu","year":"2022","unstructured":"Liu M, Luo G, Dong L, Mazhar M, Wang L, He W, Liu Y, Wu Q, Zhou H, Yang S (2022) Network pharmacology and in vitro experimental verification reveal the mechanism of the Hirudin in suppressing myocardial hypertrophy. Front Pharmacol 13:914518. https:\/\/doi.org\/10.3389\/fphar.2022.914518","journal-title":"Front Pharmacol"},{"key":"4557_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-017-0096-2","volume":"6","author":"J Cummings","year":"2017","unstructured":"Cummings J (2017) Disease modification and neuroprotection in neurodegenerative disorders. Transl Neurodegener 6:25. https:\/\/doi.org\/10.1186\/s40035-017-0096-2","journal-title":"Transl Neurodegener"},{"key":"4557_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mito.2019.09.010","volume":"50","author":"L Rani","year":"2020","unstructured":"Rani L, Mondal AC (2020) Emerging concepts of mitochondrial dysfunction in Parkinson\u2019s disease progression: pathogenic and therapeutic implications. Mitochondrion 50:25\u201334. https:\/\/doi.org\/10.1016\/j.mito.2019.09.010","journal-title":"Mitochondrion"},{"key":"4557_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00776-1","volume":"10","author":"T Suzuki","year":"2024","unstructured":"Suzuki T, Bono H (2024) A systematic exploration of unexploited genes for oxidative stress in Parkinson\u2019s disease. NPJ Parkinsons Dis 10:160. https:\/\/doi.org\/10.1038\/s41531-024-00776-1","journal-title":"NPJ Parkinsons Dis"},{"key":"4557_CR15","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00109-021-02071-5","volume":"99","author":"Y Niu","year":"2021","unstructured":"Niu Y, Zhang J, Dong M (2021) Nrf2 as a potential target for parkinson\u2019s disease therapy. J Mol Med (Berl) 99:917\u2013931. https:\/\/doi.org\/10.1007\/s00109-021-02071-5","journal-title":"J Mol Med (Berl)"},{"key":"4557_CR16","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s10787-024-01549-1","volume":"32","author":"T Kaur","year":"2024","unstructured":"Kaur T, Sidana P, Kaur N, Choubey V, Kaasik A (2024) Unraveling neuroprotection in Parkinson\u2019s disease: Nrf2\u2013Keap1 pathway\u2019s vital role amidst pathogenic pathways. Inflammopharmacology 32:2801\u20132820. https:\/\/doi.org\/10.1007\/s10787-024-01549-1","journal-title":"Inflammopharmacology"},{"key":"4557_CR17","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s11064-018-02706-z","volume":"44","author":"L Zhang","year":"2019","unstructured":"Zhang L, Zhang W, Zheng B, Tian N (2019) Sinomenine attenuates traumatic spinal cord injury by suppressing oxidative stress and inflammation via Nrf2 pathway. Neurochem Res 44:763\u2013775. https:\/\/doi.org\/10.1007\/s11064-018-02706-z","journal-title":"Neurochem Res"},{"key":"4557_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00580","volume":"10","author":"Y Yang","year":"2016","unstructured":"Yang Y, Wang H, Li L, Li X, Wang Q, Ding H, Wang X, Ye Z, Wu L, Zhang X, Zhou M, Pan H (2016) Sinomenine provides neuroprotection in model of traumatic brain injury via the Nrf2-ARE pathway. Front Neurosci 10:580. https:\/\/doi.org\/10.3389\/fnins.2016.00580","journal-title":"Front Neurosci"},{"key":"4557_CR19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s11064-016-2117-4","volume":"42","author":"L Luo","year":"2017","unstructured":"Luo L, Chen J, Su D, Chen M, Luo B, Pi R, Wang L, Shen W, Wang R (2017) L-F001, a multifunction ROCK inhibitor prevents 6-OHDA induced cell death through activating Akt\/GSK-3beta and Nrf2\/HO-1 signaling pathway in PC12 cells and attenuates MPTP-induced dopamine neuron toxicity in mice. Neurochem Res 42:615\u2013624. https:\/\/doi.org\/10.1007\/s11064-016-2117-4","journal-title":"Neurochem Res"},{"key":"4557_CR20","doi-asserted-by":"publisher","first-page":"10774","DOI":"10.1039\/d0fo02165b","volume":"11","author":"L Ma","year":"2020","unstructured":"Ma L, Zhang B, Liu J, Qiao C, Liu Y, Li S, Lv H (2020) Isoorientin exerts a protective effect against 6-OHDA-induced neurotoxicity by activating the AMPK\/AKT\/Nrf2 signalling pathway. Food Funct 11:10774\u201310785. https:\/\/doi.org\/10.1039\/d0fo02165b","journal-title":"Food Funct"},{"key":"4557_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.nbd.2004.08.016","volume":"18","author":"EJ Ryu","year":"2005","unstructured":"Ryu EJ, Angelastro JM, Greene LA (2005) Analysis of gene expression changes in a cellular model of Parkinson disease. Neurobiol Dis 18:54\u201374. https:\/\/doi.org\/10.1016\/j.nbd.2004.08.016","journal-title":"Neurobiol Dis"},{"key":"4557_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097880","volume":"9","author":"L-W Hu","year":"2014","unstructured":"Hu L-W, Yen J-H, Shen Y-T, Wu K-Y, Wu M-J (2014) Luteolin modulates 6-hydroxydopamine-induced transcriptional changes of stress response pathways in PC12 cells. PLoS ONE 9:e97880. https:\/\/doi.org\/10.1371\/journal.pone.0097880","journal-title":"PLoS ONE"},{"key":"4557_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.757161","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Gao L, Chen J, Li Q, Huo L, Wang Y, Wang H, Du J (2021) Pharmacological modulation of Nrf2\/HO-1 signaling pathway as a therapeutic target of parkinson\u2019s disease. Front Pharmacol 12:757161. https:\/\/doi.org\/10.3389\/fphar.2021.757161","journal-title":"Front Pharmacol"},{"key":"4557_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2025.1601366","volume":"19","author":"RN Bessetti","year":"2025","unstructured":"Bessetti RN, Litwa KA (2025) Broccoli for the brain: a review of the neuroprotective mechanisms of sulforaphane. Front Cell Neurosci 19:1601366. https:\/\/doi.org\/10.3389\/fncel.2025.1601366","journal-title":"Front Cell Neurosci"},{"key":"4557_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/srep32206","volume":"6","author":"Q Zhou","year":"2016","unstructured":"Zhou Q, Chen B, Wang X, Wu L, Yang Y, Cheng X, Hu Z, Cai X, Yang J, Sun X, Lu W, Yan H, Chen J, Ye J, Shen J, Cao P (2016) Sulforaphane protects against rotenone-induced neurotoxicity in vivo: involvement of the mTOR, Nrf2 and autophagy pathways. Sci Rep 6:32206. https:\/\/doi.org\/10.1038\/srep32206","journal-title":"Sci Rep"},{"key":"4557_CR26","doi-asserted-by":"publisher","first-page":"4890","DOI":"10.3892\/mmr.2019.10148","volume":"19","author":"B Bao","year":"2019","unstructured":"Bao B, Zhang MQ, Chen ZY, Wu XB, Xia ZB, Chai JY, Yin XP (2019) Sulforaphane prevents PC12 cells from oxidative damage via the Nrf2 pathway. Mol Med Rep 19:4890\u20134896. https:\/\/doi.org\/10.3892\/mmr.2019.10148","journal-title":"Mol Med Rep"},{"key":"4557_CR27","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3892\/mmr.2015.4657","volume":"13","author":"Q Cui","year":"2016","unstructured":"Cui Q, Li X, Zhu H (2016) Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt\/Nrf2 pathway. Mol Med Rep 13:1381\u20131388. https:\/\/doi.org\/10.3892\/mmr.2015.4657","journal-title":"Mol Med Rep"},{"key":"4557_CR28","doi-asserted-by":"publisher","first-page":"8430","DOI":"10.1038\/s41598-021-87225-8","volume":"11","author":"J-Y Park","year":"2021","unstructured":"Park J-Y, Sohn H-Y, Koh YH, Jo C (2021) Curcumin activates Nrf2 through PKC\u03b4-mediated p62 phosphorylation at Ser351. Sci Rep 11:8430. https:\/\/doi.org\/10.1038\/s41598-021-87225-8","journal-title":"Sci Rep"},{"key":"4557_CR29","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1080\/13880209.2023.2244176","volume":"61","author":"J Li","year":"2023","unstructured":"Li J, Yu J, Guo J, Liu J, Wan G, Wei X, Yang X, Shi J (2023) Nardostachys jatamansi and Levodopa combination alleviates parkinson\u2019s disease symptoms in rats through activation of Nrf2 and inhibition of NLRP3 signaling pathways. Pharm Biol 61:1175\u20131185. https:\/\/doi.org\/10.1080\/13880209.2023.2244176","journal-title":"Pharm Biol"},{"key":"4557_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1471-4159.2006.04345.x","volume":"101","author":"AY Shih","year":"2007","unstructured":"Shih AY, Erb H, Murphy TH (2007) Dopamine activates Nrf2-regulated neuroprotective pathways in astrocytes and meningeal cells. J Neurochem 101:109\u2013119. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04345.x","journal-title":"J Neurochem"},{"key":"4557_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2015.02.006","volume":"83","author":"K Jodko-Pi\u00f3recka","year":"2015","unstructured":"Jodko-Pi\u00f3recka K, Litwinienko G (2015) Antioxidant activity of dopamine and L-DOPA in lipid micelles and their cooperation with an analogue of \u03b1-tocopherol. Free Radic Biol Med 83:1\u201311. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.02.006","journal-title":"Free Radic Biol Med"},{"key":"4557_CR32","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1111\/j.1471-4159.1993.tb13642.x","volume":"61","author":"C Mytilineou","year":"1993","unstructured":"Mytilineou C, Han SK, Cohen G (1993) Toxic and protective effects of L-dopa on mesencephalic cell cultures. J Neurochem 61:1470\u20131478. https:\/\/doi.org\/10.1111\/j.1471-4159.1993.tb13642.x","journal-title":"J Neurochem"},{"key":"4557_CR33","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1002\/mds.27799","volume":"34","author":"L Boi","year":"2019","unstructured":"Boi L, Pisanu A, Greig NH, Scerba MT, Tweedie D, Mulas G, Fenu S, Carboni E, Spiga S, Carta AR (2019) Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of parkinson\u2019s disease. Mov Disord 34:1818\u20131830. https:\/\/doi.org\/10.1002\/mds.27799","journal-title":"Mov Disord"},{"key":"4557_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.freeradbiomed.2010.03.011","volume":"49","author":"A Minelli","year":"2010","unstructured":"Minelli A, Conte C, Prudenzi E, Cacciatore I, Cornacchia C, Taha E, Pinnen F (2010) N-acetyl-L-methionyl-L-Dopa-methyl ester as a dual acting drug that relieves L-Dopa-induced oxidative toxicity. Free Radic Biol Med 49:31\u201339. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.03.011","journal-title":"Free Radic Biol Med"},{"key":"4557_CR35","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.neuro.2011.05.009","volume":"32","author":"KH Park","year":"2011","unstructured":"Park KH, Choi NY, Koh SH, Park HH, Kim YS, Kim MJ, Lee SJ, Yu HJ, Lee KY, Lee YJ, Kim HT (2011) L-DOPA neurotoxicity is prevented by neuroprotective effects of erythropoietin. Neurotoxicology 32:879\u2013887. https:\/\/doi.org\/10.1016\/j.neuro.2011.05.009","journal-title":"Neurotoxicology"},{"key":"4557_CR36","doi-asserted-by":"publisher","first-page":"683577","DOI":"10.3389\/fimmu.2021.683577","volume":"12","author":"C-Q Zheng","year":"2021","unstructured":"Zheng C-Q, Fan H-X, Li X-X, Li J-J, Sheng S, Zhang F (2021) Resveratrol alleviates levodopa-induced dyskinesia in rats. Front Immunol 12:683577. https:\/\/doi.org\/10.3389\/fimmu.2021.683577","journal-title":"Front Immunol"},{"key":"4557_CR37","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22:657\u2013673. https:\/\/doi.org\/10.1038\/s41577-022-00684-6","journal-title":"Nat Rev Immunol"},{"key":"4557_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41577-019-0262-0","volume":"20","author":"M Colonna","year":"2020","unstructured":"Colonna M, Brioschi S (2020) Neuroinflammation and neurodegeneration in human brain at single-cell resolution. Nat Rev Immunol 20:81\u201382. https:\/\/doi.org\/10.1038\/s41577-019-0262-0","journal-title":"Nat Rev Immunol"},{"key":"4557_CR39","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12974-016-0739-8","volume":"13","author":"J Qiu","year":"2016","unstructured":"Qiu J, Yan Z, Tao K, Li Y, Li Y, Li J, Dong Y, Feng D, Chen H (2016) Sinomenine activates astrocytic dopamine D2 receptors and alleviates neuroinflammatory injury via the CRYAB\/STAT3 pathway after ischemic stroke in mice. J Neuroinflammation 13:263. https:\/\/doi.org\/10.1186\/s12974-016-0739-8","journal-title":"J Neuroinflammation"},{"key":"4557_CR40","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.intimp.2016.09.024","volume":"40","author":"J Qiu","year":"2016","unstructured":"Qiu J, Wang M, Zhang J, Cai Q, Lu D, Li Y, Dong Y, Zhao T, Chen H (2016) The neuroprotection of Sinomenine against ischemic stroke in mice by suppressing NLRP3 inflammasome via AMPK signaling. Int Immunopharmacol 40:492\u2013500. https:\/\/doi.org\/10.1016\/j.intimp.2016.09.024","journal-title":"Int Immunopharmacol"},{"key":"4557_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1742-2094-4-23","volume":"4","author":"L Qian","year":"2007","unstructured":"Qian L, Xu Z, Zhang W, Wilson B, Hong JS, Flood PM (2007) Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase. J Neuroinflammation 4:23. https:\/\/doi.org\/10.1186\/1742-2094-4-23","journal-title":"J Neuroinflammation"},{"key":"4557_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102134","volume":"47","author":"C Zhang","year":"2021","unstructured":"Zhang C, Zhao M, Wang B, Su Z, Guo B, Qin L, Zhang W, Zheng R (2021) The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in parkinson\u2019s disease. Redox Biol 47:102134. https:\/\/doi.org\/10.1016\/j.redox.2021.102134","journal-title":"Redox Biol"},{"key":"4557_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2022.105325","volume":"156","author":"A Chakkittukandiyil","year":"2022","unstructured":"Chakkittukandiyil A, Sajini DV, Karuppaiah A, Selvaraj D (2022) The principal molecular mechanisms behind the activation of Keap1\/Nrf2\/ARE pathway leading to neuroprotective action in Parkinson\u2019s disease. Neurochem Int 105325. https:\/\/doi.org\/10.1016\/j.neuint.2022.105325","journal-title":"Neurochem Int"},{"key":"4557_CR44","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/aps.2010.122","volume":"31","author":"LH Long","year":"2010","unstructured":"Long LH, Wu PF, Chen XL, Zhang Z, Chen Y, Li YY, Jin Y, Chen JG, Wang F (2010) HPLC and LC-MS analysis of Sinomenine and its application in pharmacokinetic studies in rats. Acta Pharmacol Sin 31:1508\u20131514. https:\/\/doi.org\/10.1038\/aps.2010.122","journal-title":"Acta Pharmacol Sin"},{"key":"4557_CR45","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1016\/j.lfs.2005.05.054","volume":"77","author":"ZQ Liu","year":"2005","unstructured":"Liu ZQ, Chan K, Zhou H, Jiang ZH, Wong YF, Xu HX, Liu L (2005) The pharmacokinetics and tissue distribution of Sinomenine in rats and its protein binding ability in vitro. Life Sci 77:3197\u20133209. https:\/\/doi.org\/10.1016\/j.lfs.2005.05.054","journal-title":"Life Sci"},{"key":"4557_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155114","volume":"121","author":"J-M Li","year":"2023","unstructured":"Li J-M, Yao Y-D, Luo J-F, Liu J-X, Lu L-L, Liu Z-Q, Dong Y, Xie Y, Zhou H (2023) Pharmacological mechanisms of Sinomenine in anti-inflammatory immunity and osteoprotection in rheumatoid arthritis: a systematic review. Phytomedicine 121:155114. https:\/\/doi.org\/10.1016\/j.phymed.2023.155114","journal-title":"Phytomedicine"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04557-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-025-04557-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04557-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:10:48Z","timestamp":1761541848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-025-04557-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["4557"],"URL":"https:\/\/doi.org\/10.1007\/s11064-025-04557-x","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The Committee for Animal Experiments at Taizhou Hospital of Zhejiang Province, China, reviewed and approved all experimental protocols and animal handling procedures (approval number: tzy-2021091).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"302"}}